Search
for
Sort by
Research 61–90 of 1000+
- Superficial granulomatous pyoderma: A localized vegetative form of pyoderma gangrenosum
- Methotrexate in dermatology
- SUSPECTED CUTANEOUS DRUG TOXICITY IN RHEUMATOID ARTHRITIS—AN EVALUATION
- LUPUS ERYTHEMATOSUS AND THE SKIN
- The safety profiles of avacopan on microscopic polyangiitis and granulomatosis with polyangiitis: a real-world pharmacovigilance analysis
- Dermatological drugs, topical agents, and cosmetics
- Semaglutide-Induced Atypical Pustular Drug Eruption: A Case Report
- Erythema multiforme in a Central American tapir (Tapirus bairdii) calf, clinical case report
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- TOC
- Localization of varicella-zoster virus nucleic acids and proteins in human skin
- Topical minoxidil in the treatment of alopecia areata.
- Melanocytes: The new Black
- Persistent Alopecia in a Breast Cancer Patient Following Taxane Chemotherapy and Adjuvant Endocrine Therapy: Case Report and Review of Post-treatment Hair Loss in Oncology Patients with Breast Cancer
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- Signal Mining for Non-Bleeding Adverse Event in Novel Oral Anticoagulants: A Pharmacovigilance Study Based on the FAERS Database
- TOXIC EPIDERMAL NECROLYSIS
- The spectrum of nephrocutaneous diseases and associations
- Lupus erythematosus: systemic and cutaneous manifestations
- Obesity and the skin
- A review of diagnosis and treatment of acne in adult female patients
- Cutaneous reactions to recombinant cytokine therapy
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Toxic Epidermal Necrolysis
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- The Spectrum of Skin Disease Among Indian Children
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Adverse Reactions to Oral Retinoids An Update
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Update on the dermatologic use of systemic glucocorticosteroids